Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
269.65
250.45
229.64
211.60
161.78
171.03
117.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
269.65
250.45
229.64
211.60
161.78
171.03
117.37
Raw Material Cost
119.53
117.74
105.00
96.02
73.07
74.34
52.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
61.70
59.99
0.00
0.00
25.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.38
0.19
0.27
0.07
0.10
0.49
0.51
Selling and Distribution Expenses
70.16
67.70
57.68
59.40
45.25
40.33
32.50
Other Expenses
3.38
3.35
-2.87
-3.24
1.37
1.20
-1.61
Total Expenditure (Excl Depreciation)
223.91
219.15
195.93
183.13
132.17
127.16
94.91
Operating Profit (PBDIT) excl Other Income
45.7
31.299999999999997
33.7
28.5
29.6
43.9
22.5
Other Income
11.08
12.43
10.95
18.38
10.13
4.19
5.22
Operating Profit (PBDIT)
67.76
53.92
52.65
54.05
46.32
53.62
31.53
Interest
0.38
0.19
0.27
0.07
0.10
0.49
0.51
Exceptional Items
-1.89
4.06
2.14
-0.64
0.56
1.03
0.00
Gross Profit (PBDT)
150.13
132.71
124.64
115.58
88.70
96.69
64.52
Depreciation
10.66
9.83
8.44
7.24
6.58
5.56
3.86
Profit Before Tax
54.83
47.95
46.08
46.09
40.20
48.60
27.16
Tax
2.94
0.64
2.89
4.67
5.25
6.59
4.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.89
47.31
43.20
41.42
34.95
42.01
23.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
581.43
571.52
508.41
512.13
465.89
107.18
82.90
Earnings per share (EPS)
0.64
0.58
0.53
0.51
0.44
0.53
0.29
Diluted Earnings per share
0.64
0.58
0.53
0.51
0.44
0.53
0.29
Operating Profit Margin (Excl OI)
17.07%
12.64%
14.48%
13.44%
18.3%
25.65%
19.13%
Gross Profit Margin
24.29%
23.07%
23.74%
25.2%
28.92%
31.67%
26.43%
PAT Margin
19.25%
18.89%
18.81%
19.57%
21.6%
24.56%
19.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 7.71% vs 9.06% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 36.63% vs -0.48% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 100.00% vs -33.33% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Touchstone International Medical Science Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
269.65
0
269.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
269.65
0
269.65
Raw Material Cost
119.53
0
119.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.38
0
0.38
Selling and Distribution Expenses
70.16
0
70.16
Other Expenses
3.38
0.00
3.38
Total Expenditure (Excl Depreciation)
223.91
0
223.91
Operating Profit (PBDIT) excl Other Income
45.74
0.00
45.74
Other Income
11.08
0
11.08
Operating Profit (PBDIT)
67.76
0
67.76
Interest
0.38
0
0.38
Exceptional Items
-1.89
0
-1.89
Gross Profit (PBDT)
150.13
0
150.13
Depreciation
10.66
0
10.66
Profit Before Tax
54.83
0
54.83
Tax
2.94
0
2.94
Provisions and contingencies
0
0
0.00
Profit After Tax
51.89
0
51.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.89
0
51.89
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.89
0
51.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
581.43
0
581.43
Earnings per share (EPS)
0.64
0
0.64
Diluted Earnings per share
0.64
0
0.64
Operating Profit Margin (Excl OI)
17.07%
0%
0.00
17.07%
Gross Profit Margin
24.29%
0%
0.00
24.29%
PAT Margin
19.25%
0%
0.00
19.25%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 26.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 7.71% vs 9.06% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 5.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.67 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 36.63% vs -0.48% in Dec 2023
Annual - Interest
Interest 0.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 100.00% vs -33.33% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.07%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






